Assignee
NEUROLIXIS
FR3 patents
Top patents by PatentIndex Score
US11974992B2May 7, 2024
Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudden unexpected death in epilepsy
NEUROLIXIS0 citations53
US10562853B2Feb 18, 2020
Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-HT1A receptors
NEUROLIXIS0 citations43
US11191758B2Dec 7, 2021
Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of VMAT inhibitors
NEUROLIXIS0 citations38